Invenomic Capital Management LP bought a new stake in Mativ Holdings, Inc. (NYSE:MATV - Free Report) during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 2,221,597 shares of the company's stock, valued at approximately $13,841,000. Invenomic Capital Management LP owned approximately 4.07% of Mativ at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in MATV. D. E. Shaw & Co. Inc. lifted its holdings in Mativ by 85.9% in the 4th quarter. D. E. Shaw & Co. Inc. now owns 504,422 shares of the company's stock valued at $5,498,000 after purchasing an additional 233,125 shares in the last quarter. Allspring Global Investments Holdings LLC increased its stake in shares of Mativ by 5.6% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 4,131,328 shares of the company's stock valued at $25,986,000 after acquiring an additional 217,691 shares during the last quarter. Nuveen LLC acquired a new position in shares of Mativ during the 1st quarter valued at about $1,121,000. XTX Topco Ltd acquired a new position in shares of Mativ during the 1st quarter valued at about $1,073,000. Finally, Bridgeway Capital Management LLC increased its stake in shares of Mativ by 39.2% during the 4th quarter. Bridgeway Capital Management LLC now owns 541,432 shares of the company's stock valued at $5,902,000 after acquiring an additional 152,383 shares during the last quarter. 94.95% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of research analysts have recently commented on the stock. Zacks Research raised shares of Mativ to a "strong-buy" rating in a research note on Monday, August 11th. Wall Street Zen raised shares of Mativ from a "hold" rating to a "buy" rating in a research note on Saturday, August 9th. One analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the stock. According to MarketBeat, Mativ has an average rating of "Strong Buy" and a consensus price target of $10.00.
Read Our Latest Stock Report on MATV
Mativ Trading Down 1.8%
Shares of NYSE:MATV traded down $0.22 during trading on Wednesday, reaching $12.03. 81,547 shares of the stock were exchanged, compared to its average volume of 785,146. The firm's 50-day moving average price is $9.36 and its 200 day moving average price is $7.14. The firm has a market cap of $657.68 million, a price-to-earnings ratio of -1.44 and a beta of 0.83. The company has a debt-to-equity ratio of 2.65, a quick ratio of 1.21 and a current ratio of 2.37. Mativ Holdings, Inc. has a 12-month low of $4.34 and a 12-month high of $19.96.
Mativ (NYSE:MATV - Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. The company reported $0.33 earnings per share for the quarter, topping analysts' consensus estimates of $0.18 by $0.15. The firm had revenue of $525.40 million during the quarter, compared to analysts' expectations of $505.00 million. Mativ had a positive return on equity of 4.12% and a negative net margin of 23.09%. On average, sell-side analysts anticipate that Mativ Holdings, Inc. will post 1.15 earnings per share for the current fiscal year.
Mativ Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, September 26th. Shareholders of record on Friday, August 29th will be issued a $0.10 dividend. This represents a $0.40 dividend on an annualized basis and a yield of 3.3%. The ex-dividend date is Friday, August 29th. Mativ's dividend payout ratio is currently -4.79%.
Mativ Company Profile
(
Free Report)
Mativ Holdings, Inc, together with its subsidiaries, manufactures and sells specialty materials in the United States, Europe, the Asia Pacific, the Americas, and internationally. The company operates through two segments, Advanced Technical Materials and Fiber-Based Solutions. The Advanced Technical Materials manufactures and sells various engineered polymer, resin and fiber-based substrates, nets, films, adhesive tapes, and other nonwovens for the filtration, protective solutions, release liners, and healthcare end-markets.
Featured Stories

Before you consider Mativ, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mativ wasn't on the list.
While Mativ currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.